Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 11 Feb 2025 for Marinus Pharmaceuticals, INC., €9,085.
Filing timeline
BuySaleJoseph Hulihan
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Joseph Hulihan: trading record in brief
This profile gathers the share dealings of Joseph Hulihan in Marinus Pharmaceuticals, Inc., where the filings describe the role as senior executive. Between 4 February 2022 and 11 February 2025, the trades on record add up to 11 filings.
No open-market purchase appears, only 4 sales worth €56k. Besides market trades, the filings include 5 share grants.
Most recently, on 11 February 2025, the filings show a transaction worth €30k in Marinus Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joseph Hulihan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
17,155 shares@ US$0.5513.9% of flowCommon StockSEC:0001104659-25-011246:0
4,828 shares@ US$1.137.6% of flowCommon StockSEC:0001415889-24-020895:0
10,918 shares0Common StockSEC:0001415889-24-017630:0
2,814 shares@ US$9.9840.0% of flowCommon StockSEC:0001415889-24-004577:0
21,835 shares0Common StockSEC:0001415889-24-001592:0
2,889 shares@ US$9.5538.5% of flowCommon StockSEC:0001415889-23-011948:0
25,648 shares0Common StockSEC:0001415889-23-001585:0
7,718 shares0Common StockSEC:0001104659-22-065241:0
17,150 shares0Common StockSEC:0001104659-22-012787:0
9 of 9 declarations
